A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Background. Although intravenous immunoglobulin (IVIG) is expected to prevent coronary artery abnormalities of Kawasaki disease (KD) in the acute phase, the timing and effectiveness of IVIG remain to be determined. The association of timing of IVIG administration in KD patients with coronary artery...
Saved in:
| Main Authors: | Wei Li, Xiufang He, Li Zhang, Zhouping Wang, Yanfei Wang, Huimei Lin, Jia Yuan, Xiaofei Xie, Youzhen Qin, Ping Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Cardiovascular Therapeutics |
| Online Access: | http://dx.doi.org/10.1155/2021/6660407 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimizing the speed of intravenous immunoglobulin infusion for Kawasaki Disease
by: Chia-Yi Chin, MD, MS
Published: (2024-09-01) -
Sonographic Gallbladder Abnormality Is Associated with Intravenous Immunoglobulin Resistance in Kawasaki Disease
by: Chih-Jen Chen, et al.
Published: (2012-01-01) -
Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study
by: Satoki Hatano, et al.
Published: (2025-05-01) -
EXPERIENCE OF INTRAVENOUS INJECTION OF NORMAL HUMAN IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME
by: T. V. Sleptsova, et al.
Published: (2014-07-01) -
A machine learning-based model to predict intravenous immunoglobulin resistance in Kawasaki disease
by: Yuhan Xia, et al.
Published: (2025-03-01)